These data suggest that XPC deficiency compromises the DNA repair capacity in NSCLC cells, leading to an accumulation of endogenous DNA lesions, which activate the ERK pathway, and further reduce E-Cadherin expression. This evidence concerns the gene CDH1 and non-small cell lung carcinoma.